Comparison of toxicity, efficacy, and dose modifications in obese and non-obese patients receiving modified FOLFOX6 (mFOLFOX) for metastatic colorectal cancer (mCRC).
Daniel Jerzy Wojenski
No relevant relationships to disclose
Heidi D. Finnes
No relevant relationships to disclose
Ross A. Dierkhising
No relevant relationships to disclose
Kristen Beth McCullough
No relevant relationships to disclose
Steven R. Alberts
No relevant relationships to disclose